WarkentinTE. Heparin-induced thrombocytopenia, pathogenesis and management. Br J Haematol. 2003;121:535-535.
2.
CukerAGimottyPACrowtherMAWarkentinTE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia; a systematic review and meta-analysis. Blood. 2012;120:4160-4167. doi:10.1182/blood-2012-07-443051.
3.
WarkentinTESheppardJIMooreJCSigouinCSKeltonJG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008;6:1304-1312. doi:10.1111/j.1538-7836.2008.03025.x.
4.
WarkentinTE. HITlights: a career perspective on heparin-induced thrombocytopenia. Am J Hematol. 2012;87(suppl 1):s92-s99. doi:10.1002/ajh.23127.
5.
SmytheMAMehtaTPKoerberJM. Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol. Am J Health Syst Pharm. 2012;69:241-248. doi:10.2146/ajhp110313.